Continuum Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History

Continuum Advisory’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68.4K	Buy	+626	New	+$64.8K	0.01%	731
2025 Q2	–	Sell	-610	Closed	-$55.6K	–	1260
2025 Q1	$55.6K	Hold	610	–	–	0.01%	647
2024 Q4	$52.7K	Buy	610 +3	+0.5%	+$271	0.01%	651
2024 Q3	$53.6K	Buy	607 +5	+0.8%	+$475	0.01%	642
2024 Q2	$55.1K	Hold	602	–	–	0.01%	597
2024 Q1	$53.8K	Buy	+602	New	+$52.7K	0.01%	588
2023 Q4	–	Sell	-2,906	Closed	-$232K	–	482
2023 Q3	$232K	Buy	2,906 +101	+4%	+$8.14K	0.04%	403
2023 Q2	$221K	Buy	2,805 +2	+0.1%	+$157	0.04%	415
2023 Q1	$218K	Sell	2,803 -870	-24%	-$67.1K	0.04%	398
2022 Q4	$286K	Buy	+3,673	New	+$271K	0.05%	350

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Continuum Advisory's PPH Position: Q2 2026 in Review

Continuum Advisory opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 626 shares worth $68.4K. The stake represents 0.01% of the portfolio and ranks #731 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in PPH as recently as Q1 2025.

Continuum Advisory first reported a position in PPH in Q4 2022 and has held it in 10 quarters since. The position peaked at $286K in Q4 2022. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Continuum Advisory held 626 shares of VanEck Pharmaceutical ETF worth $68.4K as of Q2 2026.
VanEck Pharmaceutical ETF was a new Continuum Advisory position in Q2 2026.
VanEck Pharmaceutical ETF made up 0.01% of Continuum Advisory's portfolio in Q2 2026, its #731 holding.
Continuum Advisory first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 10 quarters since.
Continuum Advisory's VanEck Pharmaceutical ETF position peaked at $286K in Q4 2022.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.